We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Endoscopic Technique Successfully Repairs Perforated Ulcers

By HospiMedica International staff writers
Posted on 27 Oct 2009
A new study reports a 93% success rate in recent animal tests of natural orifice translumenal endoscopic surgery (NOTES) of perforated ulcers. More...


Researchers at the Mayo Clinic (Rochester, MN, USA) developed the technique, which involves the insertion of an endoscope with a suturing device into the stomach through the mouth to repair ulcers. The technique was tested in laboratory pigs, and the initial animal data suggests that the endoscopic approach necessitates less pressure than with conventional laparoscopic surgery, which could provide more cardiovascular stability for the patient. Among the other advantages mentioned by the researchers is the lack of surgical incisions, less discomfort for the patient when compared to laparoscopy (as 50% less air is introduced into the body), a shorter recovery time than in conventional surgery, and a potential ulcer-repair option for candidates too ill for conventional surgery. The researchers have received regulatory approval from the U.S. Food and Drug Administration (FDA) for using the NOTES repair in human volunteers, who will initially undergo general anesthesia and have the procedure performed in an operating room. The study was presented at the American College of Surgeons (ACS) 95th clinical congress, held during October 2009 in Chicago (IL, USA).

"Laparoscopic surgery for this condition is only 80% successful for a variety of reasons,” said senior author Juliane Bingener, M.D. "In our laboratory experiments we were over 90% successful. We also hope to ultimately reduce the risk to the patient overall and reduce postoperative complications.”

"In the future, if we can prove this technique works and have success with it, it can be done with less and less anesthesia, making the population that can undergo this procedure wider,” added study coauthor Erica Moran, M.D.

Perforated stomach ulcers typically require an operation to close the tear, but conventional open or minimally invasive surgical procedures can be problematic, particularly in seniors or younger patients with other health problems. The minimally invasive operation requires inflating the body cavity with carbon dioxide (CO2) to create a large enough workspace for manipulating the surgical probes. This process raises pressure in the peritoneum and abdominal cavity, concomitantly raising blood pressure, with obvious consequences for people with other health problems or older patients. Those same individuals are most vulnerable to problems with the more invasive open-cavity operation.

Related Links:
Mayo Clinic



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.